Cite
HARVARD Citation
Jin, N. et al. (2016). A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low‐Grade Neuroendocrine Tumors. Oncologist. pp. 785-786g. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jin, N. et al. (2016). A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low‐Grade Neuroendocrine Tumors. Oncologist. pp. 785-786g. [Online].